These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 25384028)

  • 1. Fluorescent non-peptidic RGD mimetics with high selectivity for αVβ3 vs αIIbβ3 integrin receptor: novel probes for in vivo optical imaging.
    Alsibai W; Hahnenkamp A; Eisenblätter M; Riemann B; Schäfers M; Bremer C; Haufe G; Höltke C
    J Med Chem; 2014 Dec; 57(23):9971-82. PubMed ID: 25384028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts.
    Lanzardo S; Conti L; Brioschi C; Bartolomeo MP; Arosio D; Belvisi L; Manzoni L; Maiocchi A; Maisano F; Forni G
    Contrast Media Mol Imaging; 2011; 6(6):449-58. PubMed ID: 22144022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
    Yan Y; Li Y; Zhang S; Ai C
    J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
    Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
    Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor.
    Burnett CA; Xie J; Quijano J; Shen Z; Hunter F; Bur M; Li KC; Danthi SN
    Bioorg Med Chem; 2005 Jun; 13(11):3763-71. PubMed ID: 15863003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.
    Huang CW; Li Z; Cai H; Shahinian T; Conti PS
    Mol Imaging; 2011 Aug; 10(4):284-94. PubMed ID: 21486537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag.
    Hahnenkamp A; Alsibai W; Bremer C; Höltke C
    J Control Release; 2014 Jul; 186():32-40. PubMed ID: 24815420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
    Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
    Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy.
    Zheng X; Xing D; Zhou F; Wu B; Chen WR
    Mol Pharm; 2011 Apr; 8(2):447-56. PubMed ID: 21197955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography.
    von Wallbrunn A; Höltke C; Zühlsdorf M; Heindel W; Schäfers M; Bremer C
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):745-754. PubMed ID: 17131149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrete functional motifs reside within the cytoplasmic tail of alphaV integrin subunit.
    Haas TA
    Thromb Haemost; 2008 Jan; 99(1):96-107. PubMed ID: 18217140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple N-methylation by a designed approach enhances receptor selectivity.
    Chatterjee J; Ovadia O; Zahn G; Marinelli L; Hoffman A; Gilon C; Kessler H
    J Med Chem; 2007 Nov; 50(24):5878-81. PubMed ID: 17973471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.
    Ye Y; Bloch S; Xu B; Achilefu S
    J Med Chem; 2006 Apr; 49(7):2268-75. PubMed ID: 16570923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P; Knight LC; Welch MJ
    Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
    Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
    Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.
    Themelis G; Harlaar NJ; Kelder W; Bart J; Sarantopoulos A; van Dam GM; Ntziachristos V
    Ann Surg Oncol; 2011 Nov; 18(12):3506-13. PubMed ID: 21509632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of competition binding assays for affinity to the extracellular matrix receptors, α(v)β(3) and α(IIb)β(3) integrin.
    Szabo AM; Howell NR; Pellegrini P; Greguric I; Katsifis A
    Anal Biochem; 2012 Apr; 423(1):70-7. PubMed ID: 22285979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imaging.
    Li F; Liu J; Jas GS; Zhang J; Qin G; Xing J; Cotes C; Zhao H; Wang X; Diaz LA; Shi ZZ; Lee DY; Li KC; Li Z
    Bioconjug Chem; 2010 Feb; 21(2):270-8. PubMed ID: 20102181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.